Other Information.
−Removed: During the three months ended March 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the three months ended June 30, 2024 , no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Exhibit Filing Date
File/Furnished Herewith
−Removed: Amended and Restated Bylaws of BioAtla, Inc.
−Removed: China Clinical Trial Services Agreement, dated April 8, 2022, by and between BioAtla, Inc.
−Removed: and Himalaya Therapeutics Limited Company, as amended .
−Removed: Form of Restricted Stock Unit Agreement
+Added: Amended and Restated Director Compensation Policy
+Added: Form of Non-Employee Director Restricted Stock Unit Agreement
Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
3 unchanged sentences
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
−Removed: The following materials from BioAtla’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in iXBRL (inline eXtensible Business Reporting Language):
+Added: The following materials from BioAtla’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, formatted in iXBRL (inline eXtensible Business Reporting Language):
(i) the Condensed Balance Sheets, (ii) the Condensed Statements of Operations and Comprehensive Loss, (iii) the Condensed Statements of Stockholders’ Equity (iv) the Condensed Statements of Cash Flows, and (v) Notes to Condensed Financial Statements, tagged as blocks of text and including detailed tags.
2 unchanged sentences
+ Indicates management contract or compensatory plan.
−Removed: * Portions of this exhibit have been redacted in accordance with Item 601(b)(10)(iv) of Regulation S-K.
−Removed: Annexes have been omitted pursuant to Item 601(a)(5).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: August 8, 2024
Chief Executive Officer
(Principal Executive Officer)
+Added: August 8, 2024
/s/ Richard A.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.